Johnson And Johnson

Is One-Shot Covid Vaccine Enough? Johnson And Johnson Begins Final Trial

World News | Reuters | Wednesday September 23, 2020

Johnson & Johnson said Wednesday it was entering the final Phase 3 stage of its Covid-19 vaccine clinical trial following positive results in earlier stages.

Johnson and Johnson Nasal Spray Approved For Those At Risk Of Suicide

World News | Cynthia Koons, Bloomberg | Tuesday August 4, 2020

Johnson & Johnson's Spravato has been approved as the first antidepressant for actively suicidal people, as doctors are becoming increasingly concerned about Covid-19's effect on the mental health of Americans.

Johnson & Johnson Starts Human Trial For Its COVID-19 Vaccine Candidate

World News | Reuters | Thursday July 30, 2020

Johnson & Johnson on Thursday kicked off US human safety trials for its COVID-19 vaccine after releasing details of a study in monkeys that showed its best-performing vaccine candidate offered strong protection in a single dose.

Johnson & Johnson Drops Skin Whitening Creams In India Amid Global Race Protests

India News | Reuters | Friday June 19, 2020

Johnson & Johnson has decided to stop selling skin whitening creams popular in Asia and the Middle East, it has said, after such products have come under renewed social pressure in recent weeks amid a global debate about racial inequality.

Apple, Johnson & Johnson Partner on 'Heartline' Clinical Heart Study

Indo-Asian News Service | Wednesday February 26, 2020

Johnson & Johnson, in collaboration with tech giant Apple has launched Heartline - a first-of-its-kind virtual study to explore if heart health features on Apple devices can improve health outcomes, including reducing the risk of stroke.

Johnson & Johnson Faces Possible $17 Billion Payout For Pushing Opiods

World News | Agence France-Presse | Tuesday August 27, 2019

US drugmaker Johnson & Johnson faces a potential record $17 billion damages payout Monday when an Oklahoma judge rules whether its aggressive promotion of opioid painkillers was responsible for the state's addiction epidemic.

Not Withholding Interim Compensation To Patients Who Want More: Johnson And Johnson To High Court

India News | Press Trust of India | Saturday August 10, 2019

Johnson and Johnson on Thursday told the Delhi High Court that it was not withholding payment to those patients who underwent revision surgeries for alleged faulty hip implants made by the company and want more than the interim compensation of Rs 25 lakh.

J&J Directed To Pay Rs 25 Lakh To Patients For Alleged Faulty Hip Implant

India News | Thursday May 30, 2019

The Delhi High Court on Thursday directed Johnson and Johnson to make interim payment of Rs 25 lakh each to 67 patients who have undergone revision surgeries for alleged faulty hip implants made by the company.

Child Rights Body Says J&J Baby Shampoo "Harmful", Firm Insists It's Safe

India News | Press Trust of India | Tuesday May 28, 2019

Top Indian child rights body has directed the American multinational company Johnson and Johnson to immediately withdraw a batch of its baby shampoo that it said allegedly contained "harmful" chemicals, a claim refuted by the company which asserted that its products are "safe".

Stop Selling Johnson's Baby Shampoo: Child Rights Body To States

India News | Press Trust of India | Saturday April 27, 2019

The top child rights body has asked all states to stop sale of Johnson's baby shampoo after its sample was found to be of substandard quality in a lab test.

Johnson And Johnson Ordered To Pay $29 Million In Talc Cancer Trial

World News | Reuters | Thursday March 14, 2019

A California jury on Wednesday ordered Johnson & Johnson to pay $29 million to a woman who said that asbestos in the company's talcum-powder-based products, including Johnson's Baby Powder, caused her mesothelioma.

"Inadequate": Johnson And Johnson Implant Victims Object To Compensation Package

India News | Press Trust of India | Tuesday February 19, 2019

Victims of Johnson & Johnson faulty Articular Surface Replacement (ASR) hip implants have written to the central expert committee (CEC) raising objections to the compensation package proposed by the government.

Johnson And Johnson's Faulty Hip Implants Case Closed By Supreme Court

India News | Press Trust of India | Friday January 11, 2019

The Supreme Court Friday closed the case seeking action against US-based pharma major Johnson and Johnson for implanting faulty hip implants into patients in India, saying that steps have been taken by the centre to provide compensation up to Rs 1.22 crore to them.

Samples Of Johnson And Johnson Baby Products Seized

India News | Press Trust of India | Friday December 21, 2018

Following orders of Drug Controller General of India (DCGI), drug inspectors have seized samples of various baby products of Johnson and Johnson from wholesalers, retailers and distributors across the country on Friday,

Drug Regulator Draws Johnson and Johnson Baby Powder Samples For Testing

India News | Press Trust of India | Wednesday December 19, 2018

The country's top drug regulator, the CDSCO, drew samples of Johnson and Johnson's baby powder from the company's Baddi plant in Himachal Pradesh on Wednesday amid reports that the product allegedly contained cancer-causing asbestos.